Association of Lower Serum Sclerostin Levels With Elevated Risk for Increased Arterial Stiffness: The JPOS Cohort Study - Summary - MDSpire

Association of Lower Serum Sclerostin Levels With Elevated Risk for Increased Arterial Stiffness: The JPOS Cohort Study

  • By

  • Junko Tamaki

  • Takahiro Tachiki

  • Myadagmaa Jaalkhorol

  • Namiraa Dongmei

  • Misa Komastu

  • Kouji Tsuda

  • Asako Kudo

  • Kuniyasu Kamiya

  • Katsuyasu Kouda

  • Etsuko Kajita

  • Sadanobu Kagamimori

  • Masayuki Iki

  • November 12, 2024

  • 0 min

Share

Objective:

To longitudinally investigate the relationship between serum sclerostin levels and the risk of increased arterial stiffness specifically in Japanese community-dwelling women aged ≥ 50 years.

Key Findings:
  • Increased arterial stiffness occurred in 94 women during the follow-up.
  • The rates of increased arterial stiffness were 22.2% (low tertile), 16.1% (medium tertile), and 12.4% (high tertile).
  • Odds ratios for increased arterial stiffness were 1.58 (medium tertile, P = .205) and 2.16 (low tertile, P = .027) after adjusting for age and baseline baPWV.
Interpretation:

Lower serum sclerostin levels are associated with a higher risk of increased arterial stiffness in Japanese community-dwelling women.

Limitations:
  • The study population was limited to women aged ≥ 50 years, which may affect generalizability to younger populations.
  • Potential confounding factors may not have been fully accounted for despite adjustments, which could influence the results.
Conclusion:

The findings suggest that lower serum sclerostin levels may contribute to increased arterial stiffness, indicating a potential area for further research and intervention in cardiovascular health.

Original Source(s)

Related Content